keyword
https://read.qxmd.com/read/38113859/efficacy-of-levetiracetam-as-add-on-therapy-in-the-treatment-of-seizures-in-neonates
#21
JOURNAL ARTICLE
Mathies Rondagh, Linda S De Vries, Cacha M P C D Peeters-Scholte, Selma C Tromp, Sylke J Steggerda
INTRODUCTION: There is no consensus regarding the efficacy of add-on therapy with levetiracetam (LEV) in the treatment of seizures in neonates. The aim of this study was to evaluate the efficacy of add-on therapy with LEV for achieving >80% seizure reduction after phenobarbital (PB) treatment. METHODS: Retrospective cohort study of near term neonates admitted to the neonatal intensive care unit with EEG-confirmed seizures despite treatment with PB as first-line therapy and using LEV as 2nd-, 3rd- or 4th-line treatment...
December 19, 2023: Neonatology
https://read.qxmd.com/read/38071567/-neuroprotectant-activity-of-novel-water-soluble-synthetic-neurosteroids-on-organophosphate-intoxication-and-status-epilepticus-induced-long-term-neurological-dysfunction-neurodegeneration-and-neuroinflammation
#22
JOURNAL ARTICLE
Doodipala Samba Reddy, Tanveer Singh, Sreevidhya Ramakrishnan, Madeline Huber, Xin Wu
Organophosphates (OP) and nerve agents are potent neurotoxic compounds that cause seizures, status epilepticus, brain injury or death. There are persistent long-term neurological and neurodegenerative effects that manifest months to years after the initial exposure. Current antidotes are ineffective in preventing these long-term neurobehavioral and neuropathological changes. Additionally, there are few effective neuroprotectants for mitigating the long-term effects of acute OP intoxication. We have pioneered neurosteroids as novel anticonvulsants and neuroprotectants for OP intoxication and seizures...
December 6, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38060481/analgesia-and-sedation-strategies-in-neonates-undergoing-whole-body-therapeutic-hypothermia-a-scoping-review
#23
REVIEW
Mahima Joshi, Javed Muneer, Lawrence Mbuagbaw, Ipsita Goswami
BACKGROUND: Therapeutic hypothermia (TH) is a widely practiced neuroprotective strategy for neonates with hypoxic-ischemic encephalopathy. Induced hypothermia is associated with shivering, cold pain, agitation, and distress. OBJECTIVE: This scoping review determines the breadth of research undertaken for pain and stress management in neonates undergoing hypothermia therapy, the pharmacokinetics of analgesic and sedative medications during hypothermia and the effect of such medication on short- and long-term neurological outcomes...
2023: PloS One
https://read.qxmd.com/read/38050069/-protective-activity-of-novel-hydrophilic-synthetic-neurosteroids-on-organophosphate-status-epilepticus-induced-chronic-epileptic-seizures-non-convulsive-discharges-high-frequency-oscillations-and-electrographic-ictal-biomarkers
#24
JOURNAL ARTICLE
Sreevidhya Ramakrishnan, Tanveer Singh, Doodipala Samba Reddy
Nerve agents and organophosphates (OP) are neurotoxic chemicals that induce acute seizures, status epilepticus (SE), and mortality. Long-term neurological and neurodegenerative effects manifest months to years after OP exposure. Current benzodiazepine anticonvulsants are ineffective in preventing such long-term neurobehavioral and neuropathological changes. New and effective anticonvulsants are needed for OP intoxication, especially for mitigating the long-term sequelae after acute exposure. We developed neurosteroids as novel anticonvulsants and neuroprotectants in OP exposure models...
November 30, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37977814/-neurosteroids-as-novel-anticonvulsants-for-refractory-status-epilepticus-and-medical-countermeasures-for-nerve-agents-a-15-year-journey-to-bring-ganaxolone-from-bench-to-clinic
#25
JOURNAL ARTICLE
Doodipala Samba Reddy
This article describes recent advances in the use of neurosteroids as novel anticonvulsants for refractory status epilepticus (RSE) and as medical countermeasures (MCs) for organophosphates and chemical nerve agents (OPNAs). We highlight a decade-long journey to bring the synthetic neurosteroid ganaxolone (GX) from bench to clinic. RSE, including when caused by nerve agents, is associated with devastating morbidity and permanent long-term neurological dysfunction. Although recent approval of benzodiazepines such as intranasal midazolam or diazepam and intranasal midazolam offers improved of control of acute seizures, novel anticonvulsants are needed to suppress RSE and improve neurological function outcomes...
November 17, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37977809/efficacy-of-lacosamide-and-rufinamide-as-adjuncts-to-midazolam-ketamine-treatment-against-cholinergic-induced-status-epilepticus-in-rats
#26
JOURNAL ARTICLE
Lucille A Lumley, Donna A Nguyen, Marcio de Araujo Furtado, Jerome Niquet, Emily Linz, Caroline R Schultz, Michael F Stone, Claude G Wasterlain
Benzodiazepine pharmacoresistance develops when treatment of status epilepticus (SE) is delayed. This response may result from gamma-aminobutyric acid A receptors (GABAA R) internalization that follows prolonged SE; this receptor trafficking results in fewer GABAA R in the synapse to restore inhibition. Increase in synaptic N-methyl-D-aspartate receptors (NMDAR) also occurs in rodent models of SE. Lacosamide, a third generation antiseizure medication (ASM), acts on the slow inactivation of voltage-gated sodium channels...
November 17, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37943122/a-5-year-old-boy-with-super-refractory-status-epilepticus-and-ranbp2-variant-warranting-life-saving-hemispherotomy
#27
JOURNAL ARTICLE
Barbora Straka, Miroslav Koblížek, Barbora Heřmanovská, Radka Valkovičová, Lenka Krsková, Markéta Kalinová, Markéta Vlčková, Josef Zámečník, Petra Laššuthová, Lucie Sedláčková, David Staněk, Alice Maulisová, Michal Tichý, Martin Kynčl, Pavel Kršek
Focal cortical dysplasia (FCD) represents the most common cause of drug-resistant epilepsy in adult and pediatric surgical series. However, genetic factors contributing to severe phenotypes of FCD remain unknown. We present a patient with an exceptionally rapid development of drug-resistant epilepsy evolving in super-refractory status epilepticus. We performed multiple clinical (serial EEG, MRI), biochemical (metabolic and immunological screening), genetic (WES from blood- and brain-derived DNA) and histopathological investigations...
November 9, 2023: Epilepsia Open
https://read.qxmd.com/read/37940836/postictal-encephalopathy-after-status-epilepticus-outcome-and-risk-factors
#28
JOURNAL ARTICLE
Clara Marie Bode, Simon Bruun Kristensen, Hanne Tanghus Olsen, Camilla Dyremose Cornwall, Lars Roberg, Olav Monsson, Thomas Krøigård, Palle Toft, Christoph P Beier
BACKGROUND: Postictal encephalopathy is well known after status epilepticus (SE), but its prognostic impact and triggers are unknown. Here, we aimed to establish risk factors for the development of postictal encephalopathy and to study its impact on survival after discharge. METHODS: This retrospective cohort study comprised adult patients diagnosed with first nonanoxic SE at Odense University Hospital between January 2008 and December 2017. Patients with ongoing SE at discharge or unknown treatment success were excluded...
November 8, 2023: Neurocritical Care
https://read.qxmd.com/read/37870502/using-interdisciplinary-teams-to-mitigate-the-effects-of-drug-shortages-in-palliative-care-the-case-of-lorazepam-injection
#29
JOURNAL ARTICLE
Natalie Hartung, Zainab Fatima, Danielle M Noreika, J Brian Cassel, Katie S Adams
Given the rising frequency of drug shortages in hospitals, interdisciplinary collaboration is necessary to manage medications, modify electronic medical records, and evaluate safety outcomes. One such shortage impacted lorazepam injection, a medication commonly used in palliative care to treat anxiety, agitation, and seizures. In anticipation of the lorazepam shortage in the summer of 2022, pharmacy staff collaborated with palliative care physicians to identify alternative treatment recommendations when providers were prohibited from ordering lorazepam injection...
October 23, 2023: Journal of Pain & Palliative Care Pharmacotherapy
https://read.qxmd.com/read/37864968/the-initial-treatment-in-convulsive-status-epilepticus-in-china-a-multi-center-observational-study
#30
MULTICENTER STUDY
Wei Peng, Lu Lu, Peiyu Wang, Yu Zhou, Weixi Xiong, Jinmei Li, Linyu Tian, Jie Liu, Yufeng Tang, Jun Wei, Cairong Zhu, Eugen Trinka, Dong Zhou
OBJECTIVE: To investigate the initial treatment of patients with convulsive status epilepticus (CSE) in a resource-limited region of China, and to discuss the difference of in-hospital outcomes and economic costs between those with guideline-recommended initial treatment and those without. METHODS: In this retrospective study, we screened adult patients discharged with the diagnosis of CSE in four centers in west China. Individuals with different exposure to the initial drug were divided into benzodiazepine (BDZ) and non-BDZ group for outcome comparison...
November 2023: Epilepsy Research
https://read.qxmd.com/read/37850066/out-of-hospital-rescue-medication-in-dogs-with-emergency-seizure-disorders-an-owner-perspective
#31
JOURNAL ARTICLE
Charlotte Kähn, Sofie F M Bhatti, Sebastian Meller, Nina Meyerhoff, Holger A Volk, Marios Charalambous
BACKGROUND: Emergency seizure disorders such as status epilepticus and cluster seizures are unlikely to cease spontaneously while prolonged seizure activity become progressively more resistant to treatment. Early administration of rescue medication in canine epileptic patients, in particular benzodiazepines, at seizure onset by the owners can be life-saving and brain protecting. Clinical studies in dogs evaluating the use of rescue medication in hospital environment exist, however, the owner perspective has not been assessed to date...
2023: Frontiers in Veterinary Science
https://read.qxmd.com/read/37798769/the-spectrum-of-sepsis-associated-encephalopathy-a-clinical-perspective
#32
REVIEW
Romain Sonneville, Sarah Benghanem, Lina Jeantin, Etienne de Montmollin, Marc Doman, Augustin Gaudemer, Michael Thy, Jean-François Timsit
Sepsis-associated encephalopathy is a severe neurologic syndrome characterized by a diffuse dysfunction of the brain caused by sepsis. This review provides a concise overview of diagnostic tools and management strategies for SAE at the acute phase and in the long term. Early recognition and diagnosis of SAE are crucial for effective management. Because neurologic evaluation can be confounded by several factors in the intensive care unit setting, a multimodal approach is warranted for diagnosis and management...
October 5, 2023: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/37783825/ketamine-to-prevent-endotracheal-intubation-in-adults-with-refractory-non-convulsive-status-epilepticus-a-case-series
#33
JOURNAL ARTICLE
Maryam J Syed, Deepti Zutshi, Syeda Maria Muzammil, Wazim Mohamed
BACKGROUND: Non-convulsive status epilepticus (NCSE) is defined as status epilepticus (SE) with no obvious motor phenomenon and is diagnosed based on electroencephalogram (EEG). Refractory SE (RSE) is the persistence of seizures despite treatment with an adequately dosed first-line and second-line agents. Although guidelines for convulsive RSE include third-line agents such as intravenous anesthetic drugs (midazolam, propofol, or barbiturates), the therapeutic approach to NCSE is not well outlined...
October 3, 2023: Neurocritical Care
https://read.qxmd.com/read/37783824/a-comparison-of-ketamine-and-midazolam-as-first-line-anesthetic-infusions-for-pediatric-status-epilepticus
#34
JOURNAL ARTICLE
Marin Jacobwitz, Caitlyn Mulvihill, Michael C Kaufman, Alexander K Gonzalez, Karla Resendiz, Conall Francoeur, Ingo Helbig, Alexis A Topjian, Nicholas S Abend
BACKGROUND: Pediatric refractory status epilepticus (RSE) often requires management with anesthetic infusions, but few data compare first-line anesthetics. This study aimed to compare the efficacy and adverse effects of midazolam and ketamine infusions as first-line anesthetics for pediatric RSE. METHODS: Retrospective single-center study of consecutive study participants treated with ketamine or midazolam as the first-line anesthetic infusions for RSE at a quaternary care children's hospital from December 1, 2017, until September 15, 2021...
October 2, 2023: Neurocritical Care
https://read.qxmd.com/read/37770202/-sex-differences-in-organophosphate-model-of-benzodiazepine-refractory-status-epilepticus-and-neuronal-damage
#35
JOURNAL ARTICLE
Tanveer Singh, Sreevidhya Ramakrishnan, Xin Wu, Doodipala Samba Reddy
Sex differences are common in human epilepsy. Although men are more susceptible to seizure than women, the mechanisms underlying sex-specific vulnerabilities to seizure are unclear. The organophosphate (OP), diisopropylfluorophosphate (DFP), is known to cause neurotoxicity and status epilepticus (SE), a serious neurologic condition that causes prolonged seizures and brain damage. Current therapies for OP poisoning and SE do not consider neuronal variations between male and female brains. Therefore, we investigated sex-dependent differences in electrographic seizure activity and neuronal injury using the DFP model of refractory SE in rats...
September 28, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37770198/evaluation-of-midazolam-ketamine-allopregnanolone-combination-therapy-against-cholinergic-induced-status-epilepticus-in-rats
#36
JOURNAL ARTICLE
Donna Nguyen, Michael F Stone, Caroline R Schultz, Marcio de Araujo Furtado, Jerome Niquet, Claude G Wasterlain, Lucille A Lumley
Status epilepticus (SE) is a life-threatening development of self-sustaining seizures that becomes resistant to benzodiazepines when treatment is delayed. Benzodiazepine pharmacoresistance is thought in part to result from internalization of synaptic GABAA receptors, which are the main target of the drug. The naturally occurring neurosteroid allopregnanolone is a therapy of interest against SE for its ability to modulate all isoforms of GABAA receptors. Ketamine, an NMDA receptor antagonist, has been partially effective in combination with benzodiazepines in mitigating SE-associated neurotoxicity...
September 28, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37739807/preventing-long-term-brain-damage-by-nerve-agent-induced-status-epilepticus-in-rat-models-applicable-to-infants-significant-neuroprotection-by-tezampanel-combined-with-caramiphen-but-not-by-midazolam-treatment
#37
JOURNAL ARTICLE
Marcio De Araujo Furtado, Vassiliki Aroniadou-Anderjaska, Taiza H Figueiredo, Volodymyr I Pidoplichko, James P Apland, Katia Rossetti, Maria F M Braga
Acute exposure to nerve agents induces a peripheral cholinergic crisis and prolonged status epilepticus (SE), causing death or long-term brain damage. To provide preclinical data pertinent to the protection of infants and newborns, we compared the antiseizure and neuroprotective effects of treating soman-induced SE with midazolam (MDZ) versus tezampanel (LY293558) in combination with caramiphen (CRM), in 12- and 7-day-old rats. The anticonvulsants were administered 1 h after soman exposure; neuropathology data were collected up to 6 months post-exposure...
September 22, 2023: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/37661688/dyskinesia-due-to-mexiletine-overdose-a-rare-presentation
#38
Zeynelabidin Öztürk, Orkun Aydın, İlknur Bodur, Raziye Merve Yaradılmış, Hale Atalay Çelik, Nilden Tuygun
BACKGROUND: Mexiletine, a class IB antiarrhythmic, is a structural analog of lidocaine. Our knowledge of mexiletine overdose is based on lidocaine overdose reports. Only a few cases of mexiletine overdose have been reported, including fatal overdoses. Mexiletine toxicity primarily affects the central nervous, cardiovascular, and gastrointestinal systems. CASE: A 16-year-old female was brought to our hospital by ambulance after taking an unknown dose of mexiletine in a suicide attempt...
2023: Turkish Journal of Pediatrics
https://read.qxmd.com/read/37655702/treatment-of-seizures-in-the-neonate-guidelines-and-consensus-based-recommendations-special-report-from-the-ilae-task-force-on-neonatal-seizures
#39
JOURNAL ARTICLE
Ronit M Pressler, Nicholas S Abend, Stéphan Auvin, Geraldine Boylan, Francesco Brigo, Maria Roberta Cilio, Linda S De Vries, Maurizio Elia, Alberto Espeche, Cecil D Hahn, Terrie Inder, Nathalie Jette, Angelina Kakooza-Mwesige, Silke Mader, Eli M Mizrahi, Solomon L Moshé, Lakshmi Nagarajan, Iris Noyman, Magda L Nunes, Pauline Samia, Eilon Shany, Renée A Shellhaas, Ann Subota, Chahnez Charfi Triki, Tammy Tsuchida, Kollencheri Puthenveettil Vinayan, Jo M Wilmshurst, Elissa G Yozawitz, Hans Hartmann
Seizures are common in neonates, but there is substantial management variability. The Neonatal Task Force of the International League Against Epilepsy (ILAE) developed evidence-based recommendations about antiseizure medication (ASM) management in neonates in accordance with ILAE standards. Six priority questions were formulated, a systematic literature review and meta-analysis were performed, and results were reported following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 standards...
October 2023: Epilepsia
https://read.qxmd.com/read/37643794/-chronic-epilepsy-and-mossy-fiber-sprouting-following-organophosphate-induced-status-epilepticus-in-rats
#40
JOURNAL ARTICLE
Robert E Blair, Elisa Hawkins, Lauren R Pinchbeck, Robert J DeLorenzo, Laxmikant S Deshpande
Organophosphate (OP) compounds are highly toxic and include pesticides and chemical warfare nerve agents (CWNA). OP exposure inhibits the acetylcholinesterase enzyme, causing cholinergic overstimulation that can evolve into status epilepticus (SE) and produce lethality. Furthermore, OP-induced SE survival is associated with mood and memory dysfunction and spontaneous recurrent seizures (SRS). In Male Sprague-Dawley rats, we assessed hippocampal pathology and chronic SRS following SE induced by administration of OP agents POX (2 mg/kg, s...
August 29, 2023: Journal of Pharmacology and Experimental Therapeutics
keyword
keyword
104823
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.